MedPath

Examining the Effect of Nutritional Supplementation on Skeletal Muscle Mass in Patients Awaiting Lung Transplant

Not Applicable
Conditions
Lung Transplant; Complications
Interventions
Dietary Supplement: Ensure Enlive
Registration Number
NCT04522388
Lead Sponsor
Johns Hopkins University
Brief Summary

This non-randomized pilot study aims to investigate whether a protein rich nutritional shake (Ensure Enlive) given to patients pre-transplant will decrease skeletal muscle loss (measured by quadriceps ultrasound) and improve nutritional state (measured by Nutritional Risk Index). A nutritional supplement would be a cost-effective solution to treat malnutrition, a known risk factor implicated in poor outcomes for lung transplant recipients.

Detailed Description

Not available

Recruitment & Eligibility

Status
ENROLLING_BY_INVITATION
Sex
All
Target Recruitment
25
Inclusion Criteria
  • Subjects 18 years or older who are listed for single or double lung transplant
  • Subject provides written informed consent to participate in this study
Exclusion Criteria
  • Subject with history of Galactosemia
  • Subject with history of milk protein allergy
  • Subject with history of soy protein allergy

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
TreatmentEnsure EnliveNutritional shakes, Ensure Enlive, twice per day orally in patients awaiting lung transplant
Primary Outcome Measures
NameTimeMethod
Effect of nutritional supplementation on skeletal muscle mass as assessed by ultrasound of the quadricepsPre-transplant

To examine the effect of nutritional supplementation on skeletal muscle mass in patients with end stage lung disease who are awaiting lung transplant, measured by ultrasound of the quadriceps.

Secondary Outcome Measures
NameTimeMethod
Effect of nutritional supplementation on Nutritional Risk index as assessed by serum albumin levelPre-transplant

To examine the effect of nutritional supplementation on Nutritional Risk index, measured by serum albumin level.

Trial Locations

Locations (1)

Johns Hopkins Hospital

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath